Directory
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Degree: PhD

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publications

  • Matías-Guiu X.; Barriuso J.; Aranda I.; Capdevila J.; Cuatrecasas M.; González E.; González-Campora R.; Jiménez-Fonseca P.; Vilardell F.; García-Carbonero R.

    Recomendaciones para la Determinación de Biomarcadores en Tumores Endocrinos Gastroenteropancreáticos. Consenso nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica

    Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia 46 222-236. .

    [doi:10.1016/j.patol.2013.06.004]

  • Arjo, Gemma; Capell, Teresa; Matias-Guiu, Xavier; Zhu, Changfu; Christou, Paul; Pinol, Carme

    Mice fed on a diet enriched with genetically engineered multivitamin corn show no sub-acute toxic effects and no sub-chronic toxicity

    PLANT BIOTECHNOLOGY JOURNAL 10 1026-1034. .

    [doi:10.1111/j.1467-7652.2012.00730.x]

  • Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier

    Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

    MOLECULAR ONCOLOGY 6 530-541. .

    [doi:10.1016/j.molonc.2012.06.006]

  • Colas, Eva; Pedrola, Nuria; Devis, Laura; Ertekin, Tugce; Campoy, Irene; Martinez, Elena; Llaurado, Marta; Rigau, Marina; Olivan, Mireia; Garcia, Marta; Cabrera, Silvia; Gil-Moreno, Antonio; Xercavins, Jordi; Castellvi, Josep; Garcia, Angel; Ramon y Cajal, Santiago; Moreno-Bueno, Gema; Dolcet, Xavier; Alameda, Francesc; Palacios, Jose; Prat, Jaime; Doll, Andreas; Matias-Guiu, Xavier; Abal, Miguel; Reventos, Jaume

    The EMT signaling pathways in endometrial carcinoma

    CLINICAL & TRANSLATIONAL ONCOLOGY 14 715-720. .

    [doi:10.1007/s12094-012-0866-3]

  • Armengol, AM; Susagna, MV; Gou-Fabregas, M; Santacana, M; VILARDELL, F; Matias-Guiu, X; Martin, ME

    Loss of Sprouty1 accelerates PTEN-induced tumor formation by suppressing cellular senescence

    FEBS Journal 279 167-167. .

  • Macia, A.; Gallel, P.; Vaquero, M.; Gou-Fabregas, M.; Santacana, M.; Maliszewska, A.; Robledo, M.; Gardiner, J. R.; Basson, M. A.; Matias-Guiu, X.; Encinas, M.

    Sprouty1 is a candidate tumor-suppressor gene in medullary thyroid carcinoma

    ONCOGENE 31 3961-3972. .

    [doi:10.1038/onc.2011.556]

  • Silva, Elvio G.; Matias-Guiu, Xavier

    Clonality in gynecologic neoplasms: is it time to reevaluate clonality studies in gynecologic neoplasms? Is it possible to confirm multicentricity with clonality studies?

    ANNALS OF DIAGNOSTIC PATHOLOGY 16 312-314. .

    [doi:10.1016/j.anndiagpath.2012.01.007]

  • Llaurado, Marta; Ruiz, Anna; Majem, Blanca; Ertekin, Tugce; Colas, Eva; Pedrola, Nuria; Devis, Laura; Rigau, Marina; Sequeiros, Tamara; Montes, Melania; Garcia, Marta; Cabrera, Silvia; Gil-Moreno, Antonio; Xercavins, Jordi; Castellvi, Josep; Garcia, Angel; Ramon y Cajal, Santiago; Moreno, Gema; Alameda, Francesc; Vazquez-Levin, Monica; Palacios, Jose; Prat, Jaime; Doll, Andreas; Matias-Guiu, Xavier; Abal, Miguel; Reventos, Jaume

    Molecular bases of endometrial cancer: New roles for new actors in the diagnosis and the therapy of the disease

    MOLECULAR AND CELLULAR ENDOCRINOLOGY 358 244-255. .

    [doi:10.1016/j.mce.2011.10.003]

  • Castelblanco, Esmeralda; Gallel, Pilar; Ros, Susana; Gatius, Sonia; Valls, Joan; De-Cubas, Aguirre A.; Maliszewska, Agnieszka; Yebra-Pimentel, M. Teresa; Menarguez, Javier; Gamallo, Carlos; Opocher, Giuseppe; Robledo, Mercedes; Matias-Guiu, Xavier

    Thyroid paraganglioma. Report of 3 cases and description of an immunohistochemical profile useful in the differential diagnosis with medullary thyroid carcinoma, based on complementary DNA array results

    HUMAN PATHOLOGY 43 1103-1112. .

    [doi:10.1016/j.humpath.2011.08.022]

  • Vilardell, Felip; Novell, Anna; Martin, Javier; Santacana, Maria; Velasco, Ana; Diez-Castro, M. J.; Cuevas, Dolors; Jose Panades, M.; Gonzalez, Serafin; Llombart, Antonio; Iglesias, Edelmiro; Matias-Guiu, Xavier

    Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA

    VIRCHOWS ARCHIV 460 569-575. .

    [doi:10.1007/s00428-012-1241-z]

  • Montserrat, Nuria; Mozos, Ana; Llobet, David; Dolcet, Xavier; Pons, Cristina; Garcia de Herreros, Antonio; Matias-Guiu, Xavier; Prat, Jaime

    Epithelial to mesenchymal transition in early stage endometrioid endometrial carcinoma

    HUMAN PATHOLOGY 43 632-643. .

    [doi:10.1016/j.humpath.2011.06.021]

  • Eritja, Nuria; Mirantes, Cristina; Llobet, David; Masip, Gemma; Matias-Guiu, Xavier; Dolcet, Xavi

    ER alpha-mediated repression of pro-inflammatory cytokine expression by glucocorticoids reveals a crucial role for TNF alpha and IL1 alpha in lumen formation and maintenance

    JOURNAL OF CELL SCIENCE 125 1929-1944. .

    [doi:10.1242/jcs.095067]

Projects

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Incorporación de nuevas areas temáticas y nuevos grupos al consorcio CIBER
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU